{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:50:27Z","timestamp":1791658227662,"version":"4.3.4"},"reference-count":62,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"am","delay-in-days":379,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006034","name":"University of Southern California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006034","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["K01EB035649"],"award-info":[{"award-number":["K01EB035649"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["CA262815"],"award-info":[{"award-number":["CA262815"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["HL121365"],"award-info":[{"award-number":["HL121365"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["GM140929"],"award-info":[{"award-number":["GM140929"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["HD107206"],"award-info":[{"award-number":["HD107206"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["EB029122"],"award-info":[{"award-number":["EB029122"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["K01EB034321"],"award-info":[{"award-number":["K01EB034321"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.cell.2025.02.035","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T01:58:50Z","timestamp":1743731930000},"page":"2621-2636.e20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Engineering sonogenetic EchoBack-CAR T cells"],"prefix":"10.1016","volume":"188","author":[{"given":"Longwei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peixiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dulei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiliang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjia","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linshan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Woo","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyu","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunshu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianze","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifa","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Kay","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0265-326X","authenticated-orcid":false,"given":"Yingxiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2025.02.035_bib1","doi-asserted-by":"crossref","first-page":"224ra25","DOI":"10.1126\/scitranslmed.3008226","article-title":"Efficacy and toxicity management of 19\u201328z CAR T cell therapy in B cell acute lymphoblastic leukemia","volume":"6","author":"Davila","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2025.02.035_bib2","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1215134","article-title":"Chimeric antigen receptor-modified T cells for acute lymphoid leukemia","volume":"368","author":"Grupp","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2025.02.035_bib3","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-021-04390-6","article-title":"Decade-long leukaemia remissions with persistence of CD4+ CAR T cells","volume":"602","author":"Melenhorst","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.cell.2025.02.035_bib4","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/mt.2010.24","article-title":"Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2","volume":"18","author":"Morgan","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cell.2025.02.035_bib5","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1200\/JCO.2006.05.9964","article-title":"Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience","volume":"24","author":"Lamers","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cell.2025.02.035_bib6","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1042\/BST20160037","article-title":"Treatment of metastatic renal cell carcinoma (mRCC) with CAIX CAR-engineered T-cells-a completed study overview","volume":"44","author":"Lamers","year":"2016","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.cell.2025.02.035_bib7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13045-016-0378-7","article-title":"Cocktail treatment with EGFR-specific and CD133-specific chimeric antigen receptor-modified T cells in a patient with advanced cholangiocarcinoma","volume":"10","author":"Feng","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cell.2025.02.035_bib8","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1158\/1078-0432.CCR-17-0432","article-title":"Phase I Study of Chimeric Antigen Receptor-Modified T Cells in Patients with EGFR-Positive Advanced Biliary Tract Cancers","volume":"24","author":"Guo","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2025.02.035_bib9","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s13238-017-0440-4","article-title":"Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers","volume":"9","author":"Feng","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.cell.2025.02.035_bib10","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s00262-017-2034-7","article-title":"The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity","volume":"66","author":"Thistlethwaite","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cell.2025.02.035_bib11","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s41591-022-01800-8","article-title":"Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results","volume":"28","author":"Qi","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2025.02.035_bib12","doi-asserted-by":"crossref","first-page":"103941","DOI":"10.1016\/j.ebiom.2022.103941","article-title":"Improving CAR-T immunotherapy: overcoming the challenges of T cell exhaustion","volume":"77","author":"Gumber","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cell.2025.02.035_bib13","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","article-title":"Defining \u2018T cell exhaustion\u2019","volume":"19","author":"Blank","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cell.2025.02.035_bib14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41586-022-05692-z","article-title":"TET2 guards against unchecked BATF3-induced CAR T cell expansion","volume":"615","author":"Jain","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.cell.2025.02.035_bib15","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.immuni.2020.07.011","article-title":"Chimeric Antigen Receptor Designed to Prevent Ubiquitination and Downregulation Showed Durable Antitumor Efficacy","volume":"53","author":"Li","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2025.02.035_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41571-022-00704-3","article-title":"Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours","volume":"20","author":"Flugel","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cell.2025.02.035_bib17","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood-2013-03-490565","article-title":"Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma","volume":"122","author":"Linette","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.cell.2025.02.035_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tibtech.2014.10.006","article-title":"Synthetic immunology: modulating the human immune system","volume":"33","author":"Geering","year":"2015","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.cell.2025.02.035_bib19","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s44222-023-00042-8","article-title":"Remote control of cellular immunotherapy","volume":"1","author":"Huang","year":"2023","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.cell.2025.02.035_bib20","doi-asserted-by":"crossref","first-page":"168628","DOI":"10.1016\/j.jmb.2024.168628","article-title":"Spatiotemporal Control of Inflammatory Lytic Cell Death Through Optogenetic Induction of RIPK3 Oligomerization","volume":"436","author":"Oh","year":"2024","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.cell.2025.02.035_bib21","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev-bioeng-062117-121147","article-title":"Synthetic Biology: Immunotherapy by Design","volume":"20","author":"Brenner","year":"2018","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.cell.2025.02.035_bib22","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/s41551-021-00779-w","article-title":"Control of the activity of CAR-T cells within tumours via focused ultrasound","volume":"5","author":"Wu","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.cell.2025.02.035_bib23","doi-asserted-by":"crossref","first-page":"8317","DOI":"10.1016\/S0021-9258(18)53098-2","article-title":"Analysis of heat shock element recognition by saturation mutagenesis of the human HSP70.1 gene promoter","volume":"268","author":"Cunniff","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cell.2025.02.035_bib24","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/j.ymthe.2017.06.008","article-title":"Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase","volume":"25","author":"Walker","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cell.2025.02.035_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41568-020-00323-z","article-title":"Recent advances and discoveries in the mechanisms and functions of CAR T cells","volume":"21","author":"Larson","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2025.02.035_bib26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ymthe.2022.08.018","article-title":"Balancing activation and co-stimulation of CAR tunes signaling dynamics and enhances therapeutic potency","volume":"31","author":"Duan","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cell.2025.02.035_bib27","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1038\/s41467-021-25323-x","article-title":"Integration of FRET and sequencing to engineer kinase biosensors from mammalian cell libraries","volume":"12","author":"Liu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2025.02.035_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abb5191","article-title":"Chimeric STAR receptors using TCR machinery mediate robust responses against solid tumors","volume":"13","author":"Liu","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2025.02.035_bib29","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1476-5381.2011.01800.x","article-title":"Modulation of T cell immune functions by the prostaglandin E(2) - cAMP pathway in chronic inflammatory states","volume":"166","author":"Brudvik","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cell.2025.02.035_bib30","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1021\/acssynbio.0c00238","article-title":"Thermal Control of Engineered T-cells","volume":"9","author":"Abedi","year":"2020","journal-title":"ACS Synth. Biol."},{"key":"10.1016\/j.cell.2025.02.035_bib31","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/s41551-021-00781-2","article-title":"Enhanced intratumoural activity of CAR T cells engineered to produce immunomodulators under photothermal control","volume":"5","author":"Miller","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.cell.2025.02.035_bib32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1158\/2326-6066.CIR-17-0211","article-title":"High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma Model","volume":"6","author":"Richman","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.cell.2025.02.035_bib33","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1074\/mcp.M115.052720","article-title":"Structural Basis of GD2 Ganglioside and Mimetic Peptide Recognition by 14G2a Antibody","volume":"14","author":"Horwacik","year":"2015","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.cell.2025.02.035_bib34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.omto.2018.11.003","article-title":"Functional Analysis of an Inducible Promoter Driven by Activation Signals from a Chimeric Antigen Receptor","volume":"12","author":"Uchibori","year":"2019","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.cell.2025.02.035_bib35","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1002\/acg2.84","article-title":"TRUCKS, the fourth-generation CAR T cells: Current developments and clinical translation","volume":"3","author":"Chmielewski","year":"2020","journal-title":"Adv. Cell Gene Ther."},{"key":"10.1016\/j.cell.2025.02.035_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aay8248","article-title":"4\u20131BB costimulation promotes CAR T cell survival through noncanonical NF-\u03baB signaling","volume":"13","author":"Philipson","year":"2020","journal-title":"Sci. Signal."},{"key":"10.1016\/j.cell.2025.02.035_bib37","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1021\/acsbiomaterials.0c00233","article-title":"Label-Free Magnetic-Field-Assisted Assembly of Layer-on-Layer Cellular Structures","volume":"6","author":"Gupta","year":"2020","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.cell.2025.02.035_bib38","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/s41591-024-02875-1","article-title":"Locoregional delivery of IL-13R\u03b12-targeting CAR-T cells in recurrent high-grade glioma: a phase 1 trial","volume":"30","author":"Brown","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2025.02.035_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba1786","article-title":"Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling","volume":"372","author":"Weber","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.cell.2025.02.035_bib40","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/978-3-642-17969-3_15","article-title":"Phosphodiesterases as targets for modulating T-cell responses","author":"Bj\u00f8rgo","year":"2011","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.cell.2025.02.035_bib41","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1007\/s10528-023-10374-0","article-title":"ALOX5AP is an Indicator for High CD8 Lymphocyte Infiltration and \"Hot\" Tumor Microenvironment in Osteosarcoma: A Bioinformatic Study","volume":"61","author":"Chen","year":"2023","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.cell.2025.02.035_bib42","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMoa1610497","article-title":"Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy","volume":"375","author":"Brown","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2025.02.035_bib43","doi-asserted-by":"crossref","first-page":"5983","DOI":"10.3390\/cancers14235983","article-title":"Efficacy, Safety, and Challenges of CAR T-Cells in the Treatment of Solid Tumors","volume":"14","author":"Chen","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.cell.2025.02.035_bib44","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s00268-005-0544-5","article-title":"Expression of prostate-specific membrane antigen in normal and malignant human tissues","volume":"30","author":"Kinoshita","year":"2006","journal-title":"World J. Surg."},{"key":"10.1016\/j.cell.2025.02.035_bib45","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1158\/0008-5472.CAN-15-0159","article-title":"Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice","volume":"75","author":"Liu","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2025.02.035_bib46","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1158\/0008-5472.CAN-15-0139","article-title":"Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity","volume":"75","author":"Caruso","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2025.02.035_bib47","doi-asserted-by":"crossref","first-page":"115135","DOI":"10.1016\/j.addr.2023.115135","article-title":"Cellular and molecular imaging of CAR-T cell-based immunotherapy","volume":"203","author":"Liu","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.cell.2025.02.035_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1141","article-title":"Engineering chimeric antigen receptor T cells for solid tumour therapy","volume":"12","author":"Liu","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.cell.2025.02.035_bib49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s42003-021-01664-7","article-title":"Synthetic promoters to induce immune-effectors into the tumor microenvironment","volume":"4","author":"Greenshpan","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.cell.2025.02.035_bib50","doi-asserted-by":"crossref","first-page":"7169","DOI":"10.1038\/s41598-022-11021-1","article-title":"High throughput screen for the improvement of inducible promoters for tumor microenvironment cues","volume":"12","author":"Sharabi","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cell.2025.02.035_bib51","doi-asserted-by":"crossref","first-page":"7431","DOI":"10.3390\/ijms23137431","article-title":"The Contribution of the Minimal Promoter Element to the Activity of Synthetic Promoters Mediating CAR Expression in the Tumor Microenvironment","volume":"23","author":"Greenshpan","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cell.2025.02.035_bib52","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jbiosc.2012.05.006","article-title":"Heat-inducible transgene expression system incorporating a positive feedback loop of transcriptional amplification for hyperthermia-induced gene therapy","volume":"114","author":"Yamaguchi","year":"2012","journal-title":"J. Biosci. Bioeng."},{"key":"10.1016\/j.cell.2025.02.035_bib53","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cell.2016.09.011","article-title":"Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors","volume":"167","author":"Roybal","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cell.2025.02.035_bib54","doi-asserted-by":"crossref","first-page":"97","DOI":"10.12703\/P6-97","article-title":"MyD88: a central player in innate immune signaling","volume":"6","author":"Deguine","year":"2014","journal-title":"F1000Prime Rep."},{"key":"10.1016\/j.cell.2025.02.035_bib55","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1158\/2159-8290.CD-20-0896","article-title":"A chimeric GM-CSF\/IL18 Receptor to Sustain CAR T-cell Function","volume":"11","author":"Lange","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cell.2025.02.035_bib56","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1158\/1078-0432.CCR-15-0428","article-title":"Bioactivity and Safety of IL13Ralpha2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma","volume":"21","author":"Brown","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2025.02.035_bib57","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1093\/neuonc\/noac024","article-title":"Off-the-shelf, steroid-resistant, IL13R\u03b12-specific CAR T cells for treatment of glioblastoma","volume":"24","author":"Brown","year":"2022","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.cell.2025.02.035_bib58","doi-asserted-by":"crossref","first-page":"100543","DOI":"10.1016\/j.xcrm.2022.100543","article-title":"Harnessing the chemokine system to home CAR-T cells into solid tumors","volume":"3","author":"Foeng","year":"2022","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.cell.2025.02.035_bib59","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1038\/s41467-019-11869-4","article-title":"CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors","volume":"10","author":"Jin","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2025.02.035_bib60","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/eji.201948457","article-title":"CXCR2-modified CAR-T cells have enhanced trafficking ability that improves treatment of hepatocellular carcinoma","volume":"50","author":"Liu","year":"2020","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cell.2025.02.035_bib61","doi-asserted-by":"crossref","first-page":"10444","DOI":"10.1038\/s41467-024-54477-7","article-title":"Ultrasound Control of Genomic Regulatory Toolboxes for Cancer Immunotherapy","volume":"15","author":"Wu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2025.02.035_bib62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13059-021-02584-9","article-title":"Comparison and evaluation of statistical error models for scRNA-seq","volume":"23","author":"Choudhary","year":"2022","journal-title":"Genome Biol."}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867425002715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867425002715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:05:28Z","timestamp":1747785928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867425002715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":62,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0092867425002715"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2025.02.035","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering sonogenetic EchoBack-CAR T cells","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2025.02.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}